Methods and materials for the production of shikimic acid
View Patent ↗Novel enzymes and novel enzymatic pathways for the pyruvate-based synthesis of shikimate or at least one intermediate thereto or derivative thereof, nucleic acids encoding the enzymes, cells transformed therewith, and kits containing said enzymes, cells, or nucleic acid. A KDPGal aldolase is used to perform condensation of pyruvate with D-erythrose 4-phosphate to form 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP); a 3-dehydroquinate synthase is used to convert the DAHP to 3-dehydroquinate (DHQ); DHQ dehydratase can then convert DHQ to the key shikimate intermediate, 3-dehydroshikimate.
1. A method for converting pyruvate and erythrose 4-phosphate (E4P) to 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP), the method comprising contacting an isolated or recombinant 2-keto-3-deoxy-6-phosphogalactonate (KDPGal) aldolase having the amino acid sequence of SEQ ID NO:4 with a solution containing pyruvate and E4P.
2. The method of claim 1 further comprising contacting said DAHP with a 3-dehydroquinate (DHQ) synthase, thereby forming DHQ.
3. The method of claim 2 further comprising contacting said DHQ with a DHQ dehydratase, thereby forming 3-dehydroshikimate.
4. The method of claim 1 , wherein said method is performed within a recombinant cell.
5. The method of claim 4 , wherein said host cell was produced by transforming the cell with nucleic acid encoding at least one of a KDPGal aldolase or a DHQ synthase.
6. The method of claim 4 , wherein said recombinant cell contains at least one recombinant transketolase or at least one recombinant transaldolase.
7. A method for converting pyruvate and erythrose 4-phosphate (E4P) to 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP), comprising contacting an isolated or recombinant 2-keto-3-deoxy-6-phosphogalactonate (KDPGal) aldolase having the amino acid sequence of SEQ ID NO:4 with pyruvate and E4P, wherein said contacting converts pyruvate and E4P to DAHP.
8. The method according to claim 7 , further comprising contacting DAHP with a recombinant DHQ synthase to produce DHQ from said DAHP.
9. A process for preparing 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP), said process including the steps of:
1) providing
(A) erythrose 4-phosphate (E4P) and pyruvate,
(B) an isolated or recombinant 2-keto-3-deoxy-6-phosphogalactonate (KDPGal) aldolase having the amino acid sequence of SEQ ID NO:4, and,
(C) an aqueous medium,
2) contacting in said medium, said KDPGal aldolase with said E4P and said pyruvate under conditions suitable for said KDPGal aldolase to catalyze the formation of 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP) from the (E4P) and pyruvate.
10. A method for converting pyruvate and erythrose 4-phosphate (E4P) to 3-deoxy-D-arabino-heptulosonate-7-phosphate(DAHP), comprising contacting an isolated or recombinant 2-keto-3-deoxy-6-phosphogalactonate (KDPGal) aldolase having the amino acid sequence of SEQ ID NO:4 with pyruvate and E4P, wherein said contacting converts pyruvate and E4P to DAHP, wherein the recombinant KDPGal aldolase
comprises at least one mutation selected from the group consisting of X10V, X28L, X28M, X42T, X85A, X154F, and X196I.
11. The method of claim 7 , wherein said contacting step is performed in vivo in a recombinant cell.
12. The method of claim 7 , further comprising obtaining recombinant KDPGal aldolase from a recombinant cell, and contacting the KDPGal aldolase with pyruvate and E4P in solution to convert pyruvate and E4P to DAHP.
13. The method of claim 7 , wherein the recombinant KDPGal aldolase has a specific activity for DAHP formation in the range of 0.3 U/mg to 1.3 U/mg.
14. A method for converting pyruvate and erythrose 4-phosphate (E4P) to 3-deoxy-D-arabino-heptulosonate-7-phosphate(DAHP), comprising contacting an isolated or recombinant 2-keto-3-deoxy-6-phosphogalactonate (KDPGal) aldolase having the amino acid sequence of SEQ ID NO:4 with pyruvate and E4P, wherein said contacting converts pyruvate and E4P to DAHP, wherein the recombinant KDPGal aldolase comprises at least one mutation selected from the group consisting of X10V, X28L, X28M, X42T, X85A, X154F, and X196I, and wherein said recombinant KDPGal aldolase has higher specific activity for 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP) formation than a native KDPGal aldolase without said at least one mutation.
15. The method of claim 14 , wherein said at least one mutation is selected from the group consisting of I10V, V85A, V154F and F196I.
16. The method of claim 14 , wherein the recombinant KDPGal aldolase has no mutation that is X70L.
17. The process of claim 9 further comprising recovering DAHP from said medium.
18. The process of claim 9 further comprising:
providing a 3-dehydroquinate (DHQ) synthase, and
contacting said DAHP with said DHQ synthase under conditions suitable for said DHQ synthase to catalyze the formation of 3-dehydroquinate from the DAHP.
19. The process of claim 18 further comprising recovering at least one of DAHP, DHQ, 3-dehydroshikimate (DHS), from said medium.